Akebia Therapeutics (AKBA) Preferred Dividend Payments (2013 - 2014)
Akebia Therapeutics' (AKBA) quarterly Preferred Dividend Payments came in at -$1000.0 in Q3 2014, down 100.04% year-on-year from $2.7 million in Q3 2013, and down 200.0% on a QoQ basis from $1000.0 in Q2 2014.
Akebia Therapeutics (AKBA) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Akebia Therapeutics (AKBA) has 2 years of Preferred Dividend Payments data on file, last reported at -$1000.0 in Q3 2014.
- On a quarterly basis, Preferred Dividend Payments fell 100.04% year-over-year to -$1000.0 in Q3 2014; TTM through Dec 2014 was $86.9 million, a 55.5% increase from a year earlier, with the FY2014 full-year figure at $86.9 million, up 55.49% from the prior year.
- Preferred Dividend Payments for Q3 2014 stood at -$1000.0, down from $1000.0 in the prior quarter.
- Over the last five years, Preferred Dividend Payments for AKBA reached as high as $86.9 million in Q1 2014 and fell as low as -$1000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Akebia Therapeutics | 325.80 Mn | 163.20 Mn | 41.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | -1,000.00 |
| Jun 30, 2014 | 1,000.00 |
| Mar 31, 2014 | 86.90 Mn |
| Dec 31, 2013 | 3.02 Mn |
| Sep 30, 2013 | 2.75 Mn |
| Jun 30, 2013 | 49.27 Mn |
| Mar 31, 2013 | 848,125.00 |